Skip to content

Effectiveness of NeuroMuscular Taping on Painful Hemiplegic Shoulder

Effectiveness of NeuroMuscular Taping in a Population of Post Stroke Hemiplegic Patients Suffering From Painful Shoulder Syndrome - Randomized Controlled Trial (RCT)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02254876
Enrollment
40
Registered
2014-10-02
Start date
2013-09-30
Completion date
2015-01-31
Last updated
2015-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemiplegia

Keywords

Stroke, Hemiplegia, Painful shoulder Syndrome, NeuroMuscolar Taping

Brief summary

Painful Shoulder Syndrome is a frequent complication after stroke occurring in between 5% and 84% of patients, often having a strong impact on their well-being and resulting in delays achieving rehabilitative objectives. The aim of the study is to demonstrate the effectiveness of Neuromuscular Taping in a population of post-stroke hemiplegic patients suffering from painful shoulder syndrome with respect to pain, spasticity and range of motion.

Detailed description

The study will use two groups according to the methodology of Randomized Controlled Trials. Both components of the two groups were treated by four rehabilitation sessions defined as standard. This involves joint health and passive mobility for the glenohumeral and scapulothoracic joints for a period of about 45 minutes each. The patients of the sample group underwent the application of the NeuroMuscular Taping (NMT) before each rehabilitative session. The control group was addressed exclusively to the standard treatment. The sessions were spaced apart about five days to ensure the optimum adhesion of NMT. The results were evaluated by administering rating scales for pain (VAS) and spasticity (Modified Ashworth Scale). The ROM was evaluated using the manual goniometer. The outcomes (Pain, Spasticity, ROM) were assessed at base line, before and after each treatment session and at 1 month follow up.

Interventions

Standard physical therapy program in this study involves joint health and passive mobility at the level of the shoulder girdle and upper limb affected by Painful Shoulder Syndrome associated with the modulation of hypertonic muscle groups.

OTHERNeuroMuscular Taping (NMT)

The NeuroMuscular Taping (NMT) consists of the application on the skin of an adhesive tape with a particular structure to elastic waves and with characteristics comparable to those cutaneous. Because of these characterises it allows activation of endogenous analgesic, structural and muscular support, vascular and lymphatic activation. In this study the NMT is applied with decompressive mode on Pectoralis Major, Deltoids, Supraspinatus.

Sponsors

University of Bologna
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Right or left hemiplegia resulting from an ischemic or hemorrhagic stroke * Painful Shoulder Syndrome, with pain at rest and during functional movement of the shoulder girdle * Spasticity with an Ashworth score greater than or equal to 1.

Exclusion criteria

* Flaccidity * Thermoalgesic sensitivity deficits * Previous surgery to the shoulder * Cognitive impairment * Taking anti-inflammatory drugs and/or muscle relaxants during the course of the trial

Design outcomes

Primary

MeasureTime frameDescription
PainBefore and after each treatment session and at 1 month follow upThe investigators assessed this outcome with a Visual Analogue Scale (VAS).

Secondary

MeasureTime frameDescription
SpasticityBefore and after each treatment session and at 1 month follow upThe investigators assessed this outcome with the Modified Ashworth Scale.
ROMBefore and after each treatment session and at one month follow up.The investigators assessed this outcome using manual goniometer.

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026